The University of Edinburgh and Cancer Research UK to conduct a trial to test use of potential virus-blocking treatment in improving COVID-19 outcomes

Research title

SPIKE-1 Trial; A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion

Research organisation

Researchers:

Principal Investigator:

  • Professor Kev Dhaliwal, University of Edinburgh

Co-investigators:

  • Prof Bruce Guthrie, The University of Edinburgh
  • Prof Brian McKinstry, The University of Edinburgh
  • Prof John Norrie, The University of Edinburgh
  • Prof Daniel Anthony, University of Oxford
  • Prof Grant Churchill, University of Oxford
  • Dr Bobojon Nazarov, University of Oxford & Latus Therapeutics
  • Dr Colin Ferrett, Oxford University Hospitals NHSFT
  • Dr Suzie Anthony, Oxford University Hospitals NHSFT
  • Dr Emma Ladds, University of Oxford, Primary Care

FULL ARTICLE HERE:

Photo by SJ Objio on Unsplash

No responses yet

Leave a Reply

Your email address will not be published. Required fields are marked *